As of Mar 24
| +0.33 / +0.79%|
The 28 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 46.91, with a high estimate of 55.09 and a low estimate of 36.00. The median estimate represents a +11.96% increase from the last price of 41.90.
The current consensus among 31 polled investment analysts is to Buy stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since March, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.